Price T Rowe Associates Inc. MD Sells 706,136 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Price T Rowe Associates Inc. MD trimmed its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 26.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,951,857 shares of the company's stock after selling 706,136 shares during the quarter. Price T Rowe Associates Inc. MD owned approximately 1.15% of Option Care Health worth $45,284,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. grew its holdings in shares of Option Care Health by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock worth $448,118,000 after purchasing an additional 75,313 shares during the period. Wellington Management Group LLP lifted its holdings in Option Care Health by 84.6% during the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after buying an additional 8,400,208 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in Option Care Health by 17.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after purchasing an additional 591,042 shares during the last quarter. Norges Bank acquired a new stake in Option Care Health during the fourth quarter worth about $60,219,000. Finally, Charles Schwab Investment Management Inc. grew its position in Option Care Health by 6.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after purchasing an additional 147,054 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.64% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages have recently issued reports on OPCH. UBS Group raised shares of Option Care Health from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $38.00 to $40.00 in a research note on Wednesday. Barrington Research reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research report on Wednesday. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a research note on Tuesday, April 22nd. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $26.00 to $33.00 in a report on Monday, January 13th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $35.50.

Option Care Health Stock Up 2.4 %

Shares of Option Care Health stock traded up $0.78 during trading hours on Friday, reaching $32.95. 3,358,100 shares of the company's stock were exchanged, compared to its average volume of 1,827,653. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The stock has a market cap of $5.41 billion, a P/E ratio of 27.69, a P/E/G ratio of 2.30 and a beta of 1.07. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company has a 50 day moving average of $33.35 and a two-hundred day moving average of $28.85.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company had revenue of $1.33 billion for the quarter, compared to analyst estimates of $1.26 billion. During the same period in the prior year, the firm earned $0.26 earnings per share. The company's revenue was up 16.3% on a year-over-year basis. On average, sell-side analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.